Financials data is unavailable for this security.
View more
Year on year Stevanato Group SpA had little change in net income (from 142.85m to 145.63m) despite revenues that grew 10.34% from 983.68m to 1.09bn. A contributing factor has been an increase in the cost of goods sold as a percent of sales from 67.15% to 67.71%.
Gross margin | 30.06% |
---|---|
Net profit margin | 11.27% |
Operating margin | 15.49% |
Return on assets | 6.12% |
---|---|
Return on equity | 10.31% |
Return on investment | 8.34% |
More ▼
Cash flow in EURView more
In 2023, cash reserves at Stevanato Group SpA fell by 159.14m. Cash Flow from Financing totalled 158.03m or 14.56% of revenues. In addition the company generated 105.21m in cash from operations while cash used for investing totalled 421.22m.
Cash flow per share | 0.8447 |
---|---|
Price/Cash flow per share | 26.48 |
Book value per share | 5.40 |
---|---|
Tangible book value per share | 5.06 |
More ▼
Balance sheet in EURView more
Current ratio | 1.74 |
---|---|
Quick ratio | 1.13 |
Total debt/total equity | 0.2386 |
---|---|
Total debt/total capital | 0.1926 |
More ▼
Growth rates in EUR
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 5.88% and 1.92%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend.
Div yield(5 year avg) | 0.10% |
---|---|
Div growth rate (5 year) | -- |
Payout ratio (TTM) | 11.80% |
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | -17.11 |
More ▼